Neurometrix Inc (NURO) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neurometrix Inc   (NASDAQ: NURO)


Neurometrix Inc's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Neurometrix Inc's ROI in the fourth quarter of 2024?
Neurometrix Inc recorded a cumulative net loss of $-8 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on investment (ROI) of -46.99%.

Within the Healthcare sector 524 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2024 from 3528 to 3804.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM -20.86 % -17.2 % -14.69 % -12.04 % -10.63 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 14 16 17 19 20
Return On Investment (TTM) -46.99 % -42.45 % -41.57 % -39.63 % -31.11 %
NURO's Overall Ranking # 3804 # 3528 # 2601 # 2661 # 2206
Seq. Investment Change TTM -8.12 % -5.3 % -5.24 % -4.02 % -3.87 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -8 -8 -8 -8 -7

NURO Company Profile >> Back to NURO Roi Comparisons >> See Annual NURO Return On Investment



Return On Investment NURO's Ranking
Within: No.
Industry # 133
Sector # 525
Overall # 3804

Return On Investment Statistics
High Average Low
238.04 %
-41.1 %
-149.52 %
(Sep 30 2017)   (Mar 31 2020)



  News about Neurometrix Inc Return on Investment ROI

NeuroMetrix Explores New Horizons: A Deep Dive into the Company's Strategic Alternatives

August 13, 2024



In August 2024, NeuroMetrix, Inc., a leading player in the field of medical technology, made a significant announcement that it has initiated a comprehensive review of strategic alternatives. This move took the financial world by storm, with industry experts and investors eagerly speculating on the potential outcomes and the company s future trajectory. NeuroMetrix s pursuit of alternative strategies aims to position itself as a frontrunner in the market, conquering new horizons and delivering advanced neurodiagnostic solutions to patients worldwide. In this article, we delve into the details of this ambitious endeavor, examining the motivations behind NeuroMetrix s strategic review and the potential impact it may have on the medical technology landscape.
Unveiling NeuroMetrix s Strategic Alternatives:
NeuroMetrix s announcement on August 13, 2024, reiterated the company s commitment to exploring strategic alternatives. The objective of this review is to consider a range of possibilities that will maximize shareholder value while bolstering the company s overall growth prospects. By reevaluating its business model, NeuroMetrix hopes to identify innovative avenues that optimize revenue generation, augment market share, and fortify its market position in the neurodiagnostic sector.





Financial Statements
Neurometrix Inc's IV. Quarter Investments $ 14 Millions NURO's Balance sheet
Neurometrix Inc's IV. Quarter Income $ -2 Millions Quarterly NURO's Income Statement
NURO's Income by Division See NURO's Income by Division


NURO Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2020		 (Dec 31 2019)
2019
Total Investments in Millions 14 20 24 24 3
Y / Y Investment Growth -29.09 % -14.34 % 0.17 % 582.43 % -43.47 %
Net Income in Millions -8 -7 -4 -2 -4
Y / Y Net Income Growth - - - - -
Annual Return On Investment -54.54 % -32.35 % -18.74 % -9.7 % -109.46 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NURO's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NURO's Competitors
Subscribers only: Roi for Neurometrix Inc's Suppliers
Subscribers only: Return On Investment for NURO's Customers

Other Ratios
NURO's Roa NURO's Inventory Turnover Ratio NURO's Growth Rates NURO's Dividend Statistics
NURO's Profitability Ratios NURO's Asset Turnover Ratio NURO's Dividend Growth
NURO's Roe NURO's Valuation Ratios NURO's Financial Strength Ratios NURO's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI

Date modified: 2026-09-26T09:59:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.